Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chao‐Wei Hsu
The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan
Journal of Medical Virology
Virology
Infectious Diseases
Related publications
Editorial: Real-Life Data Confirm Efficacy of Elbasvir/Grazoprevir in HCV Patients With Severe Kidney Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial
Hepatology
Medicine
Hepatology
An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
Pmu17 - Retrospective Study of Patients Using Elbasvir/Grazoprevir in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Cost-Effectiveness Analysis of Elbasvir and Grazoprevir for Treatment of Adult Patients With Chronic Hepatitis C (Genotype 1b) From Russian Healthcare System Perspective
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
The Real-World Efficacy and Safety of Direct-Acting Oral Antiviral Treatment in Chronic Hepatitis C Genotype 1 Patients in Turkey
Cumhuriyet Medical Journal
Medicine
Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection
Acta Poloniae Pharmaceutica
Pharmacology
Pharmaceutical Science
Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
